Atlas Trials

Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease

Clinical trial NCT01510431 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT01510431
Sponsor
Mesoblast, Inc.
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Crohn's Disease

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.